β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription
Open Access
- 1 March 2003
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 23 (5) , 1674-1687
- https://doi.org/10.1128/mcb.23.5.1674-1687.2003
Abstract
β-Catenin is a multifunctional molecule that is activated by signaling through WNT receptors. β-Catenin can also enhance the transcriptional activity of some steroid hormone receptors such as the androgen receptor and retinoic acid receptor α. Androgens can affect nuclear translocation of β-catenin and influence its subcellular distribution. Using mammalian two-hybrid binding assays, analysis of reporter gene transcription, and coimmunoprecipitation, we now show that β-catenin binds to the androgen receptor ligand-binding domain (LBD) and modulates the transcriptional effects of TIF2 and the androgen receptor N-terminal domain (NTD). In functional assays, β-catenin bound to androgen receptor only in the presence of ligand agonists, not antagonists. β-Catenin binding to the androgen receptor LBD was independent of and cooperative with the androgen receptor NTD and the p160 coactivator TIF2, both of which bind to the activation function 2 (AF-2) region of the androgen receptor. Different mutations of androgen receptor helix 3 amino acids disrupted binding of androgen receptor NTD and β-catenin. β-Catenin, androgen receptor NTD, and TIF2 binding to the androgen receptor LBD were affected similarly by a subset of helix 12 mutations, but disruption of two sites on helix 12 affected only binding of β-catenin and not of TIF2 or the androgen receptor NTD. Mutational disruption of each of five LXXLL peptide motifs in the β-catenin armadillo repeats did not disrupt either binding to androgen receptor or transcriptional coactivation. ICAT, an inhibitor of T-cell factor 4 (TCF-4), and E-cadherin binding to β-catenin also blocked binding of the androgen receptor LBD. We also demonstrated cross talk between the WNT and androgen receptor signaling pathways because excess androgen receptor could interfere with WNT signaling and excess TCF-4 inhibited the interaction of β-catenin and androgen receptor. Taken together, the data show that β-catenin can bind to the androgen receptor LBD and modulate the effects of the androgen receptor NTD and TIF2 on transcription.Keywords
This publication has 67 references indexed in Scilit:
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- The Structure of the β-Catenin/E-Cadherin Complex and the Molecular Basis of Diverse Ligand Recognition by β-CateninCell, 2001
- Cross-regulation of β-catenin–LEF/TCF and retinoid signaling pathwaysCurrent Biology, 1999
- Androgen receptor gene mutations in hormone-refractory prostate cancerThe Journal of Pathology, 1999
- Structure and specificity of nuclear receptor–coactivator interactionsGenes & Development, 1998
- Antiandrogenic effect of RU-486 in the mouse kidneyThe International Journal of Biochemistry & Cell Biology, 1997
- Androgen Receptor Gene Mutations in Prostate CancerDrugs & Aging, 1997
- Androgen receptor gene amplification: A novel molecular mechanism for endocrine therapy resistance in human prostate cancerScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Androgen receptor gene amplification: A novel molecular mechanism for endocrine therapy resistance in human prostate cancerScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995